Equities

Nephros Inc

Nephros Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.81
  • Today's Change0.005 / 0.28%
  • Shares traded6.22k
  • 1 Year change+27.11%
  • Beta1.1851
Data delayed at least 15 minutes, as of Sep 19 2024 20:34 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. It operates through the Water Filtration segment. In the medical markets, it sells water filtration products. In the commercial markets, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. Its products are marketed primarily to the food service, hospitality, convenience store, and health care markets. These commercial products are also marketed into medical markets, as supplemental filtration to its medical filters. The Company’s filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.

  • Revenue in USD (TTM)13.77m
  • Net income in USD-1.29m
  • Incorporated1997
  • Employees31.00
  • Location
    Nephros Inc380 Lackawanna PlSOUTH ORANGE 07079-1704United StatesUSA
  • Phone+1 (201) 343-5202
  • Fax+1 (201) 343-5207
  • Websitehttps://www.nephros.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Euro Tech Holdings Company Ltd17.94m1.83m13.12m23.007.180.8392--0.73120.23670.23672.322.030.864921.247.58780,000.007.962.2811.173.3621.5226.209.202.831.76--0.0093--20.01-2.25395.3983.44-43.26--
Pharma-Bio Serv Inc12.93m-5.45k14.67m100.00--1.05561.221.13-0.0003-0.00030.56280.60770.7078--3.38129,331.70-0.02983.53-0.0344.0028.1028.85-0.04214.47----0.00237.03-12.48-0.939630.15-1.85-43.14--
TOMI Environmental Solutions Inc7.13m-3.41m14.81m26.00--2.03--2.08-0.1712-0.17120.35780.36450.5490.6792.02274,045.00-26.25-12.59-32.00-16.2758.5760.00-47.81-15.732.06-13.830.242---11.805.66-18.14---19.17--
Onemednet Corp1.02m-23.21m15.39m20.00------15.06-1.07-1.070.0901-0.54550.0661--11.9851,082.50-150.21---739.06---12.52---2,271.37-----11.18-----11.37---272.50------
SU Group Holdings Ltd20.34m1.26m16.92m257.0011.161.28197.840.83210.11110.11111.660.96871.213.503.7279,137.587.52--13.14--31.02--6.20--1.54153.200.0293--19.97--24.92------
Global AI Inc2.50k-1.24m16.97m1.00------6,789.73-0.0086-0.00860.00002-0.00060.1433----2,500.00-7,105.47-----------49,582.00----------------------
BTCS Inc1.65m15.78m17.95m5.001.140.57761.1410.850.97580.97580.10652.080.0766----330,990.0072.99-71.5275.63-80.3470.17--953.46-667.09---3.440.00---20.85--149.20--270.28--
Nephros Inc13.77m-1.29m18.98m31.00--2.39--1.38-0.1234-0.12341.310.75171.282.217.97444,193.60-12.05-23.35-14.11-35.4160.3855.82-9.40-30.642.62--0.0001--42.7420.1565.41------
noco-noco Inc0.00-16.79m19.16m12.00---------0.1355-0.13550.00-0.029------0.00-----------------------------1,459.39------
AmeriGuard Security Services Inc25.47m-2.13m19.21m203.00------0.7543-0.0221-0.02210.2663-0.02885.04--15.76125,482.70-42.10---178.60--13.27---8.35-----1.572.51---16.43--131.21------
Tancheng Group Co Ltd1.78m-160.18k19.80m17.00------11.13-0.0366-0.03660.4063-0.29380.5541.438.07104,711.80-4.99------20.57---9.00--0.4057------------------
Reliability Inc22.14m-570.00k21.30m172.00--2.78--0.9622-0.0019-0.00190.07380.02562.20--7.11128,697.70-5.689.87-7.1717.6614.0112.29-2.574.14----0.0275---16.61---0.1353------
Trustfeed Corp0.00-324.87k23.79m0.00---------0.0029-0.00290.00-0.00090.00-------497.85---4,805.77-------------3,564.00-----100.00---129.96------
Starbox Group Holdings Ltd12.21m-12.62m24.33m104.00--0.1741--1.99-0.1472-0.14720.17390.79830.1286--4.01117,434.40-13.23---18.50--67.72---102.84-----333.890.019--63.20---40.37------
Primech Holdings Ltd72.52m-3.24m25.23m2.74k--1.57--0.3479-0.0955-0.09552.090.42171.64610.043.9326,430.03-7.30---15.74--17.39---4.44--1.38-2.250.5347--5.07---27.93------
Data as of Sep 19 2024. Currency figures normalised to Nephros Inc's reporting currency: US Dollar USD

Institutional shareholders

40.35%Per cent of shares held by top holders
HolderShares% Held
Wexford Capital LPas of 30 Jun 20243.60m34.15%
The Vanguard Group, Inc.as of 30 Jun 2024194.02k1.84%
Bard Associates, Inc.as of 30 Jun 2024175.60k1.67%
Geode Capital Management LLCas of 30 Jun 202478.04k0.74%
Hightower Advisors LLCas of 30 Jun 202457.21k0.54%
Renaissance Technologies LLCas of 30 Jun 202441.00k0.39%
William Blair Investment Management LLCas of 30 Jun 202436.25k0.34%
Elkhorn Partners LPas of 30 Jun 202436.00k0.34%
UBS Securities LLCas of 30 Jun 202419.36k0.18%
Dimensional Fund Advisors LPas of 30 Jun 202416.58k0.16%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.